Rankings
▼
Calendar
PRTA FY 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$135M
+47.9% YoY
Gross Profit
$135M
100.0% margin
Operating Income
-$155M
-114.4% margin
Net Income
-$122M
-90.5% margin
EPS (Diluted)
$-2.27
Cash Flow
Operating Cash Flow
-$150M
Free Cash Flow
-$150M
Stock-Based Comp.
$46M
Balance Sheet
Total Assets
$547M
Total Liabilities
$60M
Stockholders' Equity
$487M
Cash & Equivalents
$471M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$135M
$91M
+47.9%
Gross Profit
$135M
$91M
+47.9%
Operating Income
-$155M
-$191M
+19.1%
Net Income
-$122M
-$147M
+16.8%
← Q4 2023
All Quarters
Q1 2024 →